|
|
Article: US FDA: Janssen Pharmaceutica announces the withdrawal of Hismanal from the market.
- Article from:
- M2 Presswire
- Article date:
- June 22, 1999
CopyrightCOPYRIGHT 1999 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-22 June 1999-US FDA: Janssen Pharmaceutica announces the withdrawal of Hismanal from the market (C)1994-99 M2 COMMUNICATIONS LTD
RDATE:210699
Janssen Pharmaceutica, Inc., of Titusville, N.J., has announced that it is voluntarily withdrawing the prescription antihistamine, Hismanal (astemizole) 10 mg., from the market.
Since the drug's approval in 1988, new adverse reaction data has required a series of labeling changes and warnings. ...
Related newspaper, magazine, and journal articles:
|
|
Article: LAB International Signs Licensing and Development Agreement for ...
M2 Presswire;
June 22, 2007 ;
700+ words
... ... Agreement for Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe(C)1994-2007 ... and development agreement with Janssen Pharmaceutica NV for Fentanyl TAIFUN(R ... Middle-East and Africa. LAB and Janssen Pharmaceutica will collaborate to develop the ...
|
|